AbbVie Inc annual shares outstanding for fiscal 2025 was 1,774 million shares, an increase of 0.1% from 1,773 million shares in fiscal 2024. Trailing-twelve-month shares outstanding is 1,774 million shares. All figures are reported results from public filings — no estimates or projections.
| Shares Outstanding (annual) | TTM | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 1,774M | 1,774M | 1,773M | 1,773M | 1,778M | 1,777M | 1,673M | 1,484M | 1,546M | 1,603M | 1,631M | 1,637M | 1,610M | 1,604M | 1,577M | 1,625M | 1,625M | 1,625M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Shares Outstanding (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 1,774M | 1,774M | 1,772M | 1,772M | 1,772M | 1,773M | 1,772M | 1,771M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ABBV metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow
All ABBV financial statements → Interactive ABBV charts →
About TickerBase · Data methodology & sources